ArticleNature communications2026

Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.

Jia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.